Cargando…
Are Hamsters a Suitable Model for Evaluating the Immunogenicity of RBD-Based Anti-COVID-19 Subunit Vaccines?
Currently, SARS-CoV-2 spike receptor-binding-domain (RBD)-based vaccines are considered one of the most effective weapons against COVID-19. During the first step of assessing vaccine immunogenicity, a mouse model is often used. In this paper, we tested the use of five experimental animals (mice, ham...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146860/ https://www.ncbi.nlm.nih.gov/pubmed/35632800 http://dx.doi.org/10.3390/v14051060 |
_version_ | 1784716666405388288 |
---|---|
author | Merkuleva, Iuliia A. Shcherbakov, Dmitry N. Borgoyakova, Mariya B. Isaeva, Anastasiya A. Nesmeyanova, Valentina S. Volkova, Natalia V. Aripov, Vazirbek S. Shanshin, Daniil V. Karpenko, Larisa I. Belenkaya, Svetlana V. Kazachinskaia, Elena I. Volosnikova, Ekaterina A. Esina, Tatiana I. Sergeev, Alexandr A. Titova, Kseniia A. Konyakhina, Yulia V. Zaykovskaya, Anna V. Pyankov, Oleg V. Kolosova, Evgeniia A. Viktorina, Olesya E. Shelemba, Arseniya A. Rudometov, Andrey P. Ilyichev, Alexander A. |
author_facet | Merkuleva, Iuliia A. Shcherbakov, Dmitry N. Borgoyakova, Mariya B. Isaeva, Anastasiya A. Nesmeyanova, Valentina S. Volkova, Natalia V. Aripov, Vazirbek S. Shanshin, Daniil V. Karpenko, Larisa I. Belenkaya, Svetlana V. Kazachinskaia, Elena I. Volosnikova, Ekaterina A. Esina, Tatiana I. Sergeev, Alexandr A. Titova, Kseniia A. Konyakhina, Yulia V. Zaykovskaya, Anna V. Pyankov, Oleg V. Kolosova, Evgeniia A. Viktorina, Olesya E. Shelemba, Arseniya A. Rudometov, Andrey P. Ilyichev, Alexander A. |
author_sort | Merkuleva, Iuliia A. |
collection | PubMed |
description | Currently, SARS-CoV-2 spike receptor-binding-domain (RBD)-based vaccines are considered one of the most effective weapons against COVID-19. During the first step of assessing vaccine immunogenicity, a mouse model is often used. In this paper, we tested the use of five experimental animals (mice, hamsters, rabbits, ferrets, and chickens) for RBD immunogenicity assessments. The humoral immune response was evaluated by ELISA and virus-neutralization assays. The data obtained show hamsters to be the least suitable candidates for RBD immunogenicity testing and, hence, assessing the protective efficacy of RBD-based vaccines. |
format | Online Article Text |
id | pubmed-9146860 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-91468602022-05-29 Are Hamsters a Suitable Model for Evaluating the Immunogenicity of RBD-Based Anti-COVID-19 Subunit Vaccines? Merkuleva, Iuliia A. Shcherbakov, Dmitry N. Borgoyakova, Mariya B. Isaeva, Anastasiya A. Nesmeyanova, Valentina S. Volkova, Natalia V. Aripov, Vazirbek S. Shanshin, Daniil V. Karpenko, Larisa I. Belenkaya, Svetlana V. Kazachinskaia, Elena I. Volosnikova, Ekaterina A. Esina, Tatiana I. Sergeev, Alexandr A. Titova, Kseniia A. Konyakhina, Yulia V. Zaykovskaya, Anna V. Pyankov, Oleg V. Kolosova, Evgeniia A. Viktorina, Olesya E. Shelemba, Arseniya A. Rudometov, Andrey P. Ilyichev, Alexander A. Viruses Article Currently, SARS-CoV-2 spike receptor-binding-domain (RBD)-based vaccines are considered one of the most effective weapons against COVID-19. During the first step of assessing vaccine immunogenicity, a mouse model is often used. In this paper, we tested the use of five experimental animals (mice, hamsters, rabbits, ferrets, and chickens) for RBD immunogenicity assessments. The humoral immune response was evaluated by ELISA and virus-neutralization assays. The data obtained show hamsters to be the least suitable candidates for RBD immunogenicity testing and, hence, assessing the protective efficacy of RBD-based vaccines. MDPI 2022-05-16 /pmc/articles/PMC9146860/ /pubmed/35632800 http://dx.doi.org/10.3390/v14051060 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Merkuleva, Iuliia A. Shcherbakov, Dmitry N. Borgoyakova, Mariya B. Isaeva, Anastasiya A. Nesmeyanova, Valentina S. Volkova, Natalia V. Aripov, Vazirbek S. Shanshin, Daniil V. Karpenko, Larisa I. Belenkaya, Svetlana V. Kazachinskaia, Elena I. Volosnikova, Ekaterina A. Esina, Tatiana I. Sergeev, Alexandr A. Titova, Kseniia A. Konyakhina, Yulia V. Zaykovskaya, Anna V. Pyankov, Oleg V. Kolosova, Evgeniia A. Viktorina, Olesya E. Shelemba, Arseniya A. Rudometov, Andrey P. Ilyichev, Alexander A. Are Hamsters a Suitable Model for Evaluating the Immunogenicity of RBD-Based Anti-COVID-19 Subunit Vaccines? |
title | Are Hamsters a Suitable Model for Evaluating the Immunogenicity of RBD-Based Anti-COVID-19 Subunit Vaccines? |
title_full | Are Hamsters a Suitable Model for Evaluating the Immunogenicity of RBD-Based Anti-COVID-19 Subunit Vaccines? |
title_fullStr | Are Hamsters a Suitable Model for Evaluating the Immunogenicity of RBD-Based Anti-COVID-19 Subunit Vaccines? |
title_full_unstemmed | Are Hamsters a Suitable Model for Evaluating the Immunogenicity of RBD-Based Anti-COVID-19 Subunit Vaccines? |
title_short | Are Hamsters a Suitable Model for Evaluating the Immunogenicity of RBD-Based Anti-COVID-19 Subunit Vaccines? |
title_sort | are hamsters a suitable model for evaluating the immunogenicity of rbd-based anti-covid-19 subunit vaccines? |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146860/ https://www.ncbi.nlm.nih.gov/pubmed/35632800 http://dx.doi.org/10.3390/v14051060 |
work_keys_str_mv | AT merkulevaiuliiaa arehamstersasuitablemodelforevaluatingtheimmunogenicityofrbdbasedanticovid19subunitvaccines AT shcherbakovdmitryn arehamstersasuitablemodelforevaluatingtheimmunogenicityofrbdbasedanticovid19subunitvaccines AT borgoyakovamariyab arehamstersasuitablemodelforevaluatingtheimmunogenicityofrbdbasedanticovid19subunitvaccines AT isaevaanastasiyaa arehamstersasuitablemodelforevaluatingtheimmunogenicityofrbdbasedanticovid19subunitvaccines AT nesmeyanovavalentinas arehamstersasuitablemodelforevaluatingtheimmunogenicityofrbdbasedanticovid19subunitvaccines AT volkovanataliav arehamstersasuitablemodelforevaluatingtheimmunogenicityofrbdbasedanticovid19subunitvaccines AT aripovvazirbeks arehamstersasuitablemodelforevaluatingtheimmunogenicityofrbdbasedanticovid19subunitvaccines AT shanshindaniilv arehamstersasuitablemodelforevaluatingtheimmunogenicityofrbdbasedanticovid19subunitvaccines AT karpenkolarisai arehamstersasuitablemodelforevaluatingtheimmunogenicityofrbdbasedanticovid19subunitvaccines AT belenkayasvetlanav arehamstersasuitablemodelforevaluatingtheimmunogenicityofrbdbasedanticovid19subunitvaccines AT kazachinskaiaelenai arehamstersasuitablemodelforevaluatingtheimmunogenicityofrbdbasedanticovid19subunitvaccines AT volosnikovaekaterinaa arehamstersasuitablemodelforevaluatingtheimmunogenicityofrbdbasedanticovid19subunitvaccines AT esinatatianai arehamstersasuitablemodelforevaluatingtheimmunogenicityofrbdbasedanticovid19subunitvaccines AT sergeevalexandra arehamstersasuitablemodelforevaluatingtheimmunogenicityofrbdbasedanticovid19subunitvaccines AT titovakseniiaa arehamstersasuitablemodelforevaluatingtheimmunogenicityofrbdbasedanticovid19subunitvaccines AT konyakhinayuliav arehamstersasuitablemodelforevaluatingtheimmunogenicityofrbdbasedanticovid19subunitvaccines AT zaykovskayaannav arehamstersasuitablemodelforevaluatingtheimmunogenicityofrbdbasedanticovid19subunitvaccines AT pyankovolegv arehamstersasuitablemodelforevaluatingtheimmunogenicityofrbdbasedanticovid19subunitvaccines AT kolosovaevgeniiaa arehamstersasuitablemodelforevaluatingtheimmunogenicityofrbdbasedanticovid19subunitvaccines AT viktorinaolesyae arehamstersasuitablemodelforevaluatingtheimmunogenicityofrbdbasedanticovid19subunitvaccines AT shelembaarseniyaa arehamstersasuitablemodelforevaluatingtheimmunogenicityofrbdbasedanticovid19subunitvaccines AT rudometovandreyp arehamstersasuitablemodelforevaluatingtheimmunogenicityofrbdbasedanticovid19subunitvaccines AT ilyichevalexandera arehamstersasuitablemodelforevaluatingtheimmunogenicityofrbdbasedanticovid19subunitvaccines |